1. Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan;
2. Laboratory of Adjuvant Innovation, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan;
3. Laboratory of Vaccine Science, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan